Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Revive Therapeutics Ltd
C.RVV
Alternate Symbol(s):
RVVTF
Healthcare
Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is...
evaluating a point-of-care in vitro diagnostic device that aids in the detection of post COVID-19 conditions or Long COVID. It also advancing the development of Psilocybin-based therapeutics through various programs. The Company's subsidiaries include Revive Therapeutics Inc. (Ontario), Revive Diagnostics Inc., and Psilocin Pharma Corp. (Ontario).
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Company Website
Add To Watchlist
Bullboard (CSE:RVV)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
(5)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Apr 29, 2022 12:45pm
Pandemic not over, US unlikely to eliminate Covid 19 !
#Bucillamine https://finnoexpert.com/2022/04/29/pandemic-not-over-us-unlikely-to-eliminate-covid-19-anthony-fauci/
(5)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Apr 28, 2022 7:52pm
Elon Musk going to buy $RVV ... sure it's a fake tweet !!
#Bucillamine https://twitter.com/revivethera/status/1519722598015193089
(618)
•••
CrazyProphet
X
View Profile
View Bullboard History
Post by
CrazyProphet
on Apr 28, 2022 7:34am
Hourglass almost done !
Merck sold $3.2 billion of its oral antiviral treatment for Covid in the first quarter, fueling the company’s strong revenue growth. Merck soundly beat Wall Street profit and revenue forecasts ?
...more
(5)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Apr 28, 2022 6:38am
The FDA is evaluating rare reports of "viral load rebound"
#Bucillamine https://www.nbcnews.com/health/health-news/covid-symptoms-may-return-taking-paxlovid-antiviral-pills-rare-cases-rcna25581
(5)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Apr 28, 2022 6:36am
Covid-19 cases that return after antiviral treatment !
#Bucillamine https://www.cnn.com/2022/04/27/health/paxlovid-covid-rebound/index.html
(618)
•••
CrazyProphet
X
View Profile
View Bullboard History
Post by
CrazyProphet
on Apr 28, 2022 12:17am
Am done with this virus big time
however it does not seem to be done with us ! Revive is on the doorstep it would appear of some major break through acceptance ! https://twitter.com/EricTopol/status/1519520007994052609?s=20&
...more
(5)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Apr 27, 2022 7:09pm
Quick Update on recent price action and upcoming catalyst
#Bucillamine May want to refresh the link below later for any comments etc., https://www.reddit.com/r/RVVTF/comments/udgcbc/quick_update_on_revives_recent_price_action_and/
(36)
•••
WeedKing81
X
View Profile
View Bullboard History
Post by
WeedKing81
on Apr 27, 2022 9:18am
NEWS UPDATES ON DALES REPORTS!
Load up now!! https://thedalesreport.com/psychedelics/details-of-revive-therapeutics-update-on-bucillamine-phase-3-trial-for-covid-treatment-pending/
(5)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Apr 26, 2022 8:53pm
$RVV - Interesting Tweets ! (only time will tell, of course)
#Bucillamine Revive Therapeutics, a company, is at the tail end of a Phase 3 study for their drug #Bucillamine to treat #Covid19! It's a potent anti-inflammatory that also has anti-viral
...more
(618)
•••
CrazyProphet
X
View Profile
View Bullboard History
Post by
CrazyProphet
on Apr 26, 2022 12:34pm
Well ????
Is this thing getting ready to explode ?????????
(36)
•••
WeedKing81
X
View Profile
View Bullboard History
Post by
WeedKing81
on Apr 26, 2022 10:41am
Just loaded up some more shares!! $$$
Should be a good week for RVV! https://www.globenewswire.com/news-release/2022/04/25/2428588/0/en/Revive-Therapeutics-Provides-Update-on-Phase-3-Clinical-Trial-for-Bucillamine-in-COVID-19.html
(0)
•••
GenevaC
X
View Profile
View Bullboard History
Post by
GenevaC
on Apr 26, 2022 6:32am
"Julia Levy Award" Recipient David Allan and Dr. John McGraw
(5)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Apr 26, 2022 6:29am
$RVV - fyi ..
#Bucillamine @Revive_RVV - in discussions with @BARDA (USA Govt.) for #Bucillamine/#CovidPill to explore securing Advanced Development & possible Commercial Scale-up Funding. https
...more
(5)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Apr 26, 2022 4:23am
W/House presses Congress to approve ‘urgent’ COVID funding !
#Bucillamine https://globalnews.ca/news/8786253/us-covid-funding-white-house-congress/
(36)
•••
WeedKing81
X
View Profile
View Bullboard History
Post by
WeedKing81
on Apr 26, 2022 12:09am
RVV NEWS-RELEASE!
This looks great! https://www.globenewswire.com/news-release/2022/04/25/2428588/0/en/Revive-Therapeutics-Provides-Update-on-Phase-3-Clinical-Trial-for-Bucillamine-in-COVID-19.html
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
New Gold and Copper Hotspot Identified – What’s Next for This Serbian Project?
Major Funding Secured! Company Closes First Round of Private Placement
This $10M Deal Could Reshape the Future of Global Creator Platforms